CORSAIR CAPITAL MANAGEMENT, L.P.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1276470 NEW YORK, NY

Position in HALO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$646,300

New position

Shares Held

10,000

first reported quarter

Ownership

0.008%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CORSAIR CAPITAL MANAGEMENT, L.P. holds $2,088,800 across 4 Biotechnology names. HALO ranks #2 (30.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IOVA	Iovance Biotherapeutics, Inc.	350,000	$1,228,500
2	HALO	Halozyme Therapeutics, Inc. This page	10,000	$646,300
3	MAIA	MAIA Biotechnology, Inc.	100,000	$140,000
4	NRXS	Neuraxis, INC	10,000	$74,000

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$646,300	10,000	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.